Wells Fargo Downgrades Medidata Solutions Inc to Market Perform

Brokerage firm Wells Fargo Downgrades its rating on Medidata Solutions Inc(NASDAQ:MDSO). The shares have been rated Market Perform. Previously, the analysts had a Outperform rating on the shares. The rating by Wells Fargo was issued on Jul 21, 2016.

In a different note, On Apr 26, 2016, Jefferies said it Downgrades its rating on Medidata Solutions Inc. The shares have been rated ‘Underperform’ by the firm. Leerink Swann said it Initiates Coverage on Medidata Solutions Inc, according to a research note issued on Apr 26, 2016. The shares have been rated ‘Market Perform’ by the firm.

Medidata Solutions Inc (MDSO) made into the market gainers list on Wednesdays trading session with the shares advancing 14.66% or 6.85 points. Due to strong positive momentum, the stock ended at $53.58, which is also near the day’s high of $54.24. The stock began the session at $48.13 and the volume stood at 20,90,880 shares. The 52-week high of the shares is $61.308 and the 52 week low is $30.22. The company has a current market capitalization of $3,070 M and it has 5,72,96,821 shares in outstanding.

Medidata Solutions Inc(MDSO) last announced its earnings results on Apr 21, 2016 for Fiscal Year 2016 and Q1.Company reported revenue of $104.24M. Analysts had an estimated revenue of $103.22M. Earnings per share were $0.25. Analysts had estimated an EPS of $0.18.

Several Insider Transactions has been reported to the SEC. On Jul 13, 2016, Vries Glen Michael De (President) sold 32,500 shares at $49.29 per share price.Also, On Jul 13, 2016, Tarek Sherif (Chairman & CEO) sold 22,036 shares at $49.24 per share price.On Jul 13, 2016, Steven Isaac Hirschfeld (Vice Chairman) sold 10,000 shares at $49.85 per share price, according to the Form-4 filing with the securities and exchange commission.

Medidata Solutions Inc. (Medidata) provides cloud-based solutions for life sciences. The Company’s solutions are Medidata Rave an electronic data capture (EDC) and clinical data management system (CDMS) solution; Medidata CTMS a clinical trial management solution; Medidata Designer a protocol design tool; Medidata Insights which offer clinical business analytics and metrics; Medidata Balance a randomization and trial supply management solution; Medidata Patient Cloud an electronic patient-reported outcome (ePRO) application; Medidata Grants Manager which develops and manages trial budgets; Medidata contract research organizations (CRO) Contractor an analytics tool; Medidata SQM a set of cloud-based site quality management dashboards; Medidata Coder a medical coding and synonym management solution; Medidata Safety Gateway which collects and transmits events and related data from the EDC system and Medidata Targeted SDV which implements risk-based monitoring strategies.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Medidata Solutions Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Medidata Solutions Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.